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SUMMARY Milia are very common superficial keratinous cysts, clinically 
seen as pearly white dome-shaped lesions with a diameter of 1-2 mm. 
Bullous pemphigoid (BP) is an autoimmune bullous disease characterized 
clinically by tense bullae on the extremities and trunk. The major target 
autoantigens of BP are BP180 and BP230. We report a 55-year-old Polish 
BP patient presenting prominent milium formation. Physical examination 
revealed multiple tense bullae on the erythemas scattered on the extremi-
ties and trunk. Histopathology revealed subepidermal blisters with infiltra-
tion of eosinophils in and around the blister. Direct immunofluorescence 
showed IgG and C3 depositions at basement membrane zone. Although 
indirect immunofluorescence of normal human skin sections was negative, 
indirect immunofluorescence of salt-split skin sections showed IgG reac-
tivity with epidermal side. Immunoblotting showed that IgG antibodies in 
the serum reacted with recombinant protein of the BP180 NC16a domain. 
ELISA of BP180, but not BP230 and type VII collagen, showed positive re-
sults. Several months after oral prednisolone therapy, multiple large milia 
appeared on the healed BP lesions. Histopathology showed cysts with flaky 
keratinous inclusions in the mid-dermis. We diagnosed the patient as BP 
with milia. Since milia are occasionally found in BP, they are not a definite 
differential criterion from epidermolysis bullosa acquisita.
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IntRODUCtIOn
Bullous pemphigoid (BP) is an autoimmune blis-
tering disease affecting the elderly. BP is character-
ized clinically by tense bullae on the extremities and 
trunk, histopathologically by subepidermal blisters 
with eosinophilic infiltration, and immunologically 
by autoantibodies to BP180 and BP230 (1). Direct im-
munofluorescence of perilesional skin showed depo-
sitions of IgG and C3 at basement membrane zone 
(BMZ). Indirect immunofluorescence of normal hu-
man skin sections as a substrate detects circulating 
IgG anti-BMZ antibodies, which react with epidermal 
side of 1M NaCl-split skin sections (1).
Immunoblotting of normal human epidermal ex-
tracts as a substrate detects IgG antibodies reactive 
with BP180 and/or BP230 (1). Immunoblotting shows 
IgG reactivity with recombinant protein of the NC16a 
domain of BP180. In some BP patients, immunoblotting 
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of concentrated culture supernatant of HaCaT cells 
shows reactivity with LAD-1, a well known autoanti-
gen in linear IgA bullous dermatosis. IgG antibodies 
in patient sera show positive results in ELISAs of 
BP180 and BP230 (1). The diagnosis of BP is now made 
by combination of these methods.
BP rarely shows prominent milium formation, 
which is a hallmark of epidermolysis bullosa acquis-
ita. We report a BP case with multiple large milia on 
the healed BP lesions, the diagnosis of which was 
confirmed by various immunological techniques.
CASE REPORt
A 55-year-old Polish female visited the Polish In-
stitute of Skin Disease in September 2010, complain-
ing of a 6-month history of generalized pruritic skin 
lesions. The diagnosis of autosensitization dermati-
tis due to intertriginous candidiasis was tentatively 
made, and the patient was treated with a combi-
nation of oral fluconazole 200 mg daily and topical 
clotrimazole/hydrocortisone, which was partially ef-
fective. However, one month later, blistering lesions 
appeared suddenly.
Physical examination revealed multiple tense bul-
lae and crusts on erythemas scattered on the trunk 
and extremities (Fig. 1a). A biopsy was taken from 
the edge of the blister on the forearm with a scalpel. 
Histopathologically, a subepidermal blister with infil-
tration of eosinophils in and around the blister was 
found. Although indirect immunofluorescence of 
normal human skin sections was negative (Fig. 1b), 
indirect immunofluorescence of 1M NaCl-split skin 
sections showed that IgG antibodies in the patient 
serum reacted with the epidermal side of the split 
(Fig. 1c).
Immunoblotting of normal epidermal extracts 
showed that the patient serum reacted with neither 
BP230 nor BP180 (Fig. 1d). Immunoblotting showed 
IgG reactivity with recombinant protein of the NC16a 
domain of BP180, while immunoblotting of recombi-
nant protein of C-terminus of BP180, purified human 
laminin-332, concentrated HaCaT cell culture super-
natants and normal human dermal extracts showed 
negative results (Fig. 1d). Index value of enzyme-
linked immunosorbent assay (ELISA) for BP180 was 
50.0 (positive: cut-off >15), that for BP230 was 1.17 
(negative: cut-off >9) and that for type VII collagen 
was 2.04 (negative: cut-off >6.14).
Although direct immunofluorescence could not 
be performed, we diagnosed this patient as having 
BP and started treatment with oral prednisolone 
50 mg daily and ranitidine 300 mg daily, combined 
with a very strong topical corticosteroid. This treat-
ment could control the lesion perfectly. One month 
later, the dose of prednisolone was reduced by 2.5 
mg every 2 weeks. However, strong pruritus and su-
perficial serous discharge occurred suddenly. Under 
suspicion of secondary bacterial infection, we started 
3 cycles of 10-day regimen of fexofenadine 180 mg 
daily and doxycycline 100 mg daily, which cured 
the skin lesions.
Seven months later, multiple large milium-like le-
sions appeared on almost all the healed BP lesions, 
particularly on the wrists (Figs. 1e,f ). A biopsy ob-
tained from the lesion showed the normal appearing 
overlying epidermis and BMZ, and multiple cysts with 
squamous epithelial cell wall and flake-like keratinous 
inclusions in the mid-dermis, confirming the diagno-
sis of milia (Fig. 1g).
DISCUSSIOn
Milia are very common benign keratinous cysts of 
the skin, clinically seen as pearly white dome-shaped 
lesions, 1-2 mm in diameter (2). Primary and second-
ary milia are known (3). Secondary milia are associat-
ed with many dermatologic disorders, including epi-
dermolysis bullosa hereditaria, epidermolysis bullosa 
acquisita, bullous lichen planus, porphyria cutanea 
tarda, burns, skin trauma, contact dermatitis, tattoo, 
cutaneous leishmaniasis, and iatrogenic application 
of nitrogen mustard or topical corticosteroids (3-5).
Concerning the association of milia with BP, there 
are conflicting systematic studies in addition to sev-
eral case reports (3,6-10). Prost et al. report that 9 
(52.9%) of 17 mucous membrane pemphigoid or 
epidermolysis bullosa acquisita patients, but none 
of 15 BP patients showed milium formation (7). In 
contrast, Venning et al. report that all 3 epidermolysis 
bullosa acquisita patients, one (11.1%) of 9 mucous 
membrane pemphigoid patients, and 7 (38.9%) of 18 
BP patients showed an association with milia (8). Fur-
thermore, using indirect immunofluorescence and 
immunoblotting, Venning et al. categorized BP into 
BP230 single positive BP (group 1), BP180 single posi-
tive BP (group 2) and indirect immunofluorescence 
positive and immunoblotting negative BP (group 3), 
and revealed that two (22%) of nine group 1 patients, 
one (17%) of six group 2 patients, and three (20%) of 
fifteen group 3 patients showed an association with 
milia (9). Finally, the largest study by Banfield et al. re-
vealed an association of milia in 23 (31.1%) of 74 BP 
patients, who showed significantly higher association 
with HLA-DQ6 (10). However, the number and size of 
milia in the previous BP cases are much less, if com-
pared with the prominent milium formation seen in 
our patients.
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Figure 1. (a) Clinical feature on the upper back at the initial appearance; (b) indirect immu-
nofluorescence of normal human skin section. No reaction to BMZ with weak cytoplasmic 
staining in the basal cells; (c) indirect immunofluorescence of 1M NaCl-split skin section; (d) 
immunoblotting of epidermal extract, recombinant proteins of BP180 NC16a and C-termi-
nal domains, HaCaT cell culture supernatant, normal human dermal extract and purified 
human laminin-332; (e,f ) clinical features of both wrists showing multiple milia; (g) histo-
pathologic feature showing a milium (HE, X200).
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Milia secondary to blisters or traumas are specu-
lated to be produced through the regeneration pro-
cess of disrupted sweat glands or hair follicles (3). 
Therefore, post-bullous milia should be temporary, 
and wait-and-see policy has been proposed (3). As 
milium formation is not very rare in BP, this is not a 
definite differential criterion from epidermolysis bul-
losa acquisita. Therefore, various immunologic diag-
nostic studies should be performed in cases of bul-
lous skin disease with milium formation.
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